Rennova Health, Inc.
RNVA · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $3,283 | $3,140 | $30 | $2,975 |
| - Cash | $49 | $124 | $726 | $251 |
| + Debt | $11,776 | $12,236 | $12,454 | $13,832 |
| Enterprise Value | $15,010 | $15,252 | $11,759 | $16,556 |
| Revenue | $3,843 | $3,538 | $6,389 | $4,916 |
| % Growth | 8.6% | -44.6% | 30% | – |
| Gross Profit | $1,856 | $1,732 | $4,555 | $2,969 |
| % Margin | 48.3% | 48.9% | 71.3% | 60.4% |
| EBITDA | -$2,073 | -$262 | $2,332 | $1,452 |
| % Margin | -53.9% | -7.4% | 36.5% | 29.5% |
| Net Income | -$9,264 | -$548 | $1,278 | $806 |
| % Margin | -241.1% | -15.5% | 20% | 16.4% |
| EPS Diluted | -0 | -0 | 0 | 0 |
| % Growth | -1,618.3% | -758.6% | 67.8% | – |
| Operating Cash Flow | $285 | -$244 | $2,206 | $1,141 |
| Capital Expenditures | -$27 | -$47 | -$57 | -$220 |
| Free Cash Flow | $258 | -$291 | $2,149 | $921 |